News: ScreenPro Expands Services to IMEs 2022-02-08 03:01 ET - News Release
Toronto, Ontario--(Newsfile Corp. - February 8, 2022) - ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) ("ScreenPro" or the "Company") is pleased to announce that the Company is expanding into the independent medical examinations (IMEs) market.
The purpose of an independent medical examination is to allow an insurance company to get a third-party medical opinion regarding a disputed issue related to a claimant's compensation claim. An IME can be requested by the insurance company to investigate the extent of an injury.
An IME examination can be requested by insurance companies, benefits providers, HR managers, lawyers, or employers. There are numerous segments within the IME market as such, the IME industry could represent a significant growth segment for the Company.
"Concierge Medical provides our clients with access to professional medical services. Adding the IME services is a natural extension. With multiple segments to focus on in the IME segment, we believe the IME could expand in a short time. Our initial focus would be on the insurance segment," said Lena Kozovski, CEO of the Company.
About ScreenPro
ScreenPro is a Screening and Medical Technology company that provides turnkey screening solutions with its proprietary medical alerting software. ScreenPro's unique access to multiple manufacturers of high-quality test kits and its strategic partnership with labs in British Columbia, Ontario and Quebec allowing ScreenPro to be a full-service nationwide provider of COVID testing solutions across Canada. In addition, ScreenPro has its own medical doctor and nursing professionals along with on the ground support staff and transportation, as access to high quality PPEs to ensure that its clients are protected in all aspects of their testing needs. ScreenPro provides alerting software through its secure GoStop application that enables individuals to use the app for test screening results as well as provides automated identification codes for our laboratories and analytics to our clients on their testing cadence.
For additional information on ScreenPro and other corporate information, please visit the Company's website at www.screenprosecurity.com.
For more information about the Company, please refer to the Company's profile on SEDAR at www.sedar.com.
Neither the Canadian Securities Exchange (the "CSE") nor it's Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
For further information please contact:
Lena Kozovski, CEO
Email: lena@screenprosecurity.com